文献速递肺栓塞与肺血管病

携带SOX17变异的肺动脉高压患者新兴表型

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants.
PubMed 文献 · Eur Respir J · 2022-12-08

该研究基于法国肺动脉高压网络,分析了20例携带SOX17致病性变异的遗传性肺动脉高压患者及8名未受影响亲属。患者诊断中位年龄17岁,多数心功能III-IV级且血流动力学严重受损,常合并先天性心脏病和咯血,影像学可见肺血管异常,病理显示严重肺动脉重塑及血管畸形,提示SOX17相关PAH为一种严重表型。

要点

  • SOX17变异相关PAH诊断中位年龄17岁,女性与男性比例1.5。
  • 74%患者诊断时NYHA心功能III或IV级,中位肺血管阻力14.0 WU。
  • 35%患者合并先天性心脏病,20%反复咯血需多次动脉栓塞。

核心结论

  • SOX17致病性变异所致PAH为严重表型,常合并先天性心脏病、咯血及影像学异常。
  • 病理显示严重肺动脉重塑及累及肺血管和胸部体循环动脉的畸形。

研究设计与样本

  • 来自法国肺动脉高压网络的遗传学分析、特征与结局报告。
  • 共纳入20例携带SOX17变异的遗传性PAH患者和8名未受影响亲属。

主要发现

  • 诊断中位年龄17岁(范围2-53),女性与男性比例为1.5。
  • 74%患者诊断时NYHA心功能III或IV级,中位肺血管阻力14.0 WU(范围4.2-31.5)。
  • 7例(35%)合并先天性心脏病,且合并先心病者诊断年龄显著更小。
  • 4例(20%)反复咯血需多次动脉栓塞;16例中13例(81%)影像可见胸部CT异常。
  • 中位随访47个月(范围1-591),10例接受肺移植,1例因合并先心病接受心肺移植。

临床怎么用

  • 对年轻PAH患者应关注SOX17变异筛查,尤其合并先天性心脏病或咯血时。
  • 影像学需注意肺血管扩张迂曲、磨玻璃影及支气管动脉异常。
  • 反复咯血者可能需要多次动脉栓塞治疗。

局限性

  • 样本量较小(20例患者),来自单一国家网络。
  • 部分患者影像资料不可用(16例中13例有影像)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The phenotype of pulmonary arterial hypertension (PAH) patients carrying SOX17 pathogenic variants remains mostly unknown. METHODS: We report the genetic analysis findings, characteristics and outcomes of patients with heritable PAH carrying SOX17 variants from the French Pulmonary Hypertension Network. RESULTS: 20 patients and eight unaffected relatives were identified. The median (range) age at diagnosis was 17 (2-53) years, with a female:male ratio of 1.5. At diagnosis, most of the patients (74%) were in New York Heart Association Functional Class III or IV with severe haemodynamic compromise, including a median pulmonary vascular resistance of 14.0 (4.2-31.5) WU. An associated congenital heart disease (CHD) was found in seven PAH patients (35%). Patients with CHD-associated PAH were significantly younger at diagnosis than PAH patients without CHD. Four patients (20%) suffered from recurrent haemoptysis requiring repeated arterial embolisations. 13 out of 16 patients (81%) for whom imaging was available displayed chest computed tomography abnormalities, including dilated, tortuous pulmonary vessels, ground-glass opacities as well as anomalies of the bronchial and nonbronchial arteries. After a median (range) follow-up of 47 (1-591) months, 10 patients underwent lung transplantation and one patient benefited from a heart-lung transplantation due to associated CHD. Histopathological analysis of lung explants showed a congested lung architecture with severe pulmonary arterial remodelling, subpleural vessel dilation and numerous haemorrhagic foci. CONCLUSIONS: PAH due to SOX17 pathogenic variants is a severe phenotype, frequently associated with CHD, haemoptysis and radiological abnormalities. Pathological assessment reveals severe pulmonary arterial remodelling and malformations affecting pulmonary vessels and thoracic systemic arteries.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Montani D, Lechartier B, Girerd B, et al. An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants. Eur Respir J. 2022. PMID: 35618278. doi:10.1183/13993003.00656-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。